Poultry Diagnostics Market

The poultry diagnostics market is projected to reach USD 0.25 billion by 2031 from USD 0.18 billion in 2026, growing at a CAGR of 7.1% during the forecast period.

The poultry diagnostics market is thriving, driven by increasing demand for fast, reliable methods of disease identification in extensive poultry production systems. The rising incidence of bird flu, as well as other highly contagious viral infections such as Newcastle disease and infectious bronchitis, has significantly heightened the need for early detection, regular flock screening, and continuous disease surveillance. Diagnostic techniques such as PCR, ELISA, and automated high-throughput systems have improved the speed and accuracy of pathogen detection. Furthermore, the booming commercial poultry sector, coupled with rising global consumption of poultry and eggs and stricter biosecurity and food safety regulations, is driving poultry farmers and veterinary laboratories to adopt more advanced diagnostic solutions. As a result, the poultry diagnostics market is experiencing steady growth, aligning with efforts to support a healthy human diet by intensifying animal protein production.

To know about the assumptions considered for the study download the pdf brochure

The key players in the poultry diagnostics market include IDEXX Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Zoetis Services LLC (US), BioChek (Netherlands), and Innovative Diagnostics (France), among others. These companies have pursued both organic and inorganic growth strategies. Their initiatives include introducing new products, forming strategic partnerships, and expanding into emerging markets. These efforts aim to increase their market share and diversify their product portfolios.

• In November 2025, Zoetis Services LLC (US) announced its acquisition of Veterinary Pathology Group (VPG), a veterinary diagnostic laboratory network operating throughout the UK and Ireland. This acquisition enhances Zoetis’ diagnostics portfolio and reinforces its commitment to advancing animal health through high-quality diagnostic solutions.
• In February 2025, BioChek (Netherlands) introduced the vetproof MS-H DIVA qPCR Kit, a real-time PCR kit designed for the detection of Mycoplasma synoviae field strains, as well as for differentiating these strains from the vaccine strain MS-H.

IDEXX Laboratories, Inc. is a global animal health and water testing company that develops, manufactures, and commercializes diagnostic products and services across companion animals, livestock, poultry, dairy, and water quality markets. It operates through three segments: Companion Animal Group (CAG), Water Quality Products, and Livestock, Poultry & Dairy (LPD). Poultry diagnostics are offered under the LPD segment, which provides tests, reagents, and related instruments to monitor and improve the health of poultry and livestock. Beyond diagnostics, IDEXX also delivers veterinary consulting, software, telemedicine, and specialized advisory services. The company has a strong international footprint, with operations in over 175 countries and subsidiaries across North America, Europe, Africa, Asia Pacific, the Middle East, and Latin America.

Zoetis Services LLC focuses on the research, development, manufacturing, and commercialization of animal health products, including vaccines, medicines, diagnostics, biodevices, and genetic tests for companion animals and livestock such as poultry, cattle, swine, and sheep. The company operates through the US and International segments and offers a broad portfolio spanning anti-infectives, vaccines, parasiticides, medicated feed additives, and animal health diagnostics. In poultry, Zoetis provides immunodiagnostic solutions, including ELISA-based antibody detection kits and rapid immunoassays, that support disease surveillance, vaccination monitoring, and control of major avian diseases. With operations in approximately 45 countries and product sales in over 100 countries, Zoetis maintains an extensive global distribution and subsidiary network.

Market Ranking

The leading companies in the poultry diagnostics market include IDEXX Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Zoetis Services LLC (US), BioChek (Netherlands), and Innovative Diagnostics (France).

IDEXX Laboratories, Inc. offers a comprehensive range of poultry diagnostics products, including ELISA test kits, nucleic acid-based assays, and automated laboratory systems designed for the rapid detection and monitoring of significant poultry diseases. Thermo Fisher Scientific Inc. is recognized for its advancements in molecular diagnostic technology. The company has developed PCR-based molecular assays, chemicals, and high-throughput equipment that allow veterinary laboratories to accurately detect poultry pathogens. Zoetis Services LLC provides a variety of poultry health management solutions, including diagnostic tools and laboratory services that facilitate quicker illness detection and monitoring, ultimately promoting the overall health of poultry. BioChek specializes in poultry diagnostics and offers ELISA and PCR test kits, as well as an automated system, the BEAR platform. This platform is designed for high-throughput disease monitoring in poultry production systems. Innovative Diagnostics focuses on immunoassay-based diagnostic kits that provide rapid and reliable detection of infectious poultry diseases, supporting routine surveillance and biosecurity programs.

Related Reports:

Poultry Diagnostics Market by Product Type (Consumable & Reagent, Instrument), Test Type (PCR, ELISA, Rapid Antigen Tests), Disease Type, Poultry Type (Broiler, Layer, Turkey, Duck & Geese), Sample Type (Swabs, Serum, Blood) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com